ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Pittsburgh, Norris Win Bristol-Myers Unrestricted Grants

April 19, 1991

In Brief: Brinkley Asks Subcommittee to Add $62.5 Million To NCI Budget for Unfunded Grants

May 11, 1979

Study Finds High-Risk Women Reluctant To Take Tamoxifen

December 25, 2009

Calif. Stem Cell Group To Collaborate With Canadians.

June 20, 2008

In Brief: NIH Study Finds Intramural Program Tenures Few Minorities, Calls For Improvements

March 11, 1994

Varmus Projects FY2011 As “Particularly Tight”

November 12, 2010